Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Elizabeth B. Rappaport"'
Autor:
Elizabeth B Rappaport, David C. Usher
Publikováno v:
Pediatric Annals. 35:822-826
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1bb4766a0f7c0cfac7f5ff61f5f454f
https://doi.org/10.3928/0090-4481-20061101-10
https://doi.org/10.3928/0090-4481-20061101-10
Autor:
Elizabeth Miller, Rita Patwardhan, Elizabeth B. Rappaport, Lawrence S. Phillips, Alan Salzman, George Grunberger
Publikováno v:
Diabetes Care. 24:308-315
OBJECTIVE— To determine the efficacy of rosiglitazone compared with placebo in reducing hyperglycemia. RESEARCH DESIGN AND METHODS— After a 4-week placebo run-in period, 959 patients were randomized to placebo or rosiglitazone (total daily dose 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a798746abd416ac5f0d8ea01e3abec5e
https://doi.org/10.2337/diacare.24.2.308
https://doi.org/10.2337/diacare.24.2.308
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 86:280-288
This study evaluated the efficacy and safety of rosiglitazone monotherapy in patients with type 2 diabetes. After a 4-week placebo run-in period, 493 patients with type 2 diabetes were randomized to receive rosiglitazone [2 or 4 mg twice daily (bd)]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db019e3cbfbb760f366570777cb3a8cb
https://doi.org/10.1210/jcem.86.1.7157
https://doi.org/10.1210/jcem.86.1.7157
Publikováno v:
Diabetologia. 43:278-284
Aims/hypothesis. The short-term efficacy, safety and tolerability of rosiglitazone were compared with placebo in patients with Type II (non-insulin-dependent) diabetes mellitus in a dose-ranging study. Methods. After a 2-week placebo run-in phase, 30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48d9bf13d8858d003c21c8033f151131
https://doi.org/10.1007/s001250050045
https://doi.org/10.1007/s001250050045
Publikováno v:
The Journal of school health. 81(6)
BACKGROUND: Limited data indicate that obese children are absent from school more than their normal-weight peers. We analyzed administrative data from a large urban school district to investigate the association of obesity and student sociodemographi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb4517154226d30e56d439e0c0b6a7c
https://pubmed.ncbi.nlm.nih.gov/21592129
https://pubmed.ncbi.nlm.nih.gov/21592129
Autor:
Elizabeth B, Rappaport
Publikováno v:
Ethnicitydisease. 17(3 Suppl 4)
The prevalence of the metabolic syndrome phenotype in children and adolescents has increased over the last decade in parallel with sharp increases in childhood overweight and obesity. Insulin resistance, blood pressure elevation, glucose intolerance,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a2538db87e3b808f0791d76e40baf5a8
https://pubmed.ncbi.nlm.nih.gov/17985723
https://pubmed.ncbi.nlm.nih.gov/17985723
Autor:
Bonita Falkner, Samuel S. Gidding, Gabriela Ramirez-Garnica, David W. West, Stacey Armatti Wiltrout, Elizabeth B. Rappaport
Publikováno v:
The Journal of pediatrics. 148(2)
To determine whether an association of overweight, or risk of overweight, and blood pressure can be detected in children in the pediatric primary care practice setting.We examined electronic medical record (EMR) data from primary care practices on 18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b554bd0dd4dcbc53aa7dfe78117ce635
https://pubmed.ncbi.nlm.nih.gov/16492428
https://pubmed.ncbi.nlm.nih.gov/16492428
Objective. The authors sought to estimate the prevalence of overweight and risk for overweight and to examine relationships between body mass index (BMI) and socioeconomic and demographic characteristics among children in Philadelphia and four neighb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf6b0f5f5c9d51a870f9bbf7b790fbef
https://europepmc.org/articles/PMC1497760/
https://europepmc.org/articles/PMC1497760/
Publikováno v:
Clinical Chemistry. 25:800-806
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::445420170bf05edc50fa96edb65ccdfb
https://doi.org/10.1093/clinchem/25.5.800
https://doi.org/10.1093/clinchem/25.5.800
Autor:
Mary M. Knapp, Elizabeth B. Rappaport
Publikováno v:
The Journal of Clinical Pharmacology. 29:463-465
First trimester exposure to isotretinoin is associated with an estimated 20% risk of major fetal malformations. Product labeling in force up to August 1988 included a statement that the drug is contraindicated in pregnancy and suggested procedures fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffa0fd6caefe0c0511aac24beef19cf8
https://doi.org/10.1002/j.1552-4604.1989.tb03363.x
https://doi.org/10.1002/j.1552-4604.1989.tb03363.x